Trial Profile
Electrophysiological measurement of anterior cingulate cortex (ACC) function in schizophrenic patients treated with Seroquel or Fluanxol.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Flupentixol
- Indications Schizophrenia
- Focus Biomarker; Therapeutic Use
- 06 Jul 2012 Status changed from recruiting to completed as reported by German Clinical Trials Register.
- 11 Jun 2012 New source identified and integrated. Added study centres, dose information and AstraZeneca as trial sponsor.
- 13 Aug 2011 New trial record